Clinical Trial

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Name: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis — clinical trial record (NCT07362017)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis

Protocol Amendment History 2 changes

critical Recruitment opened 2026-06-12

notable Trial sites expanded: 0 -> 4 locations 2026-06-12

Trial Details

NCT Number	NCT07362017
Lead Sponsor	Vanda Pharmaceuticals
Conditions	Moderate-to-severe Chronic Plaque Psoriasis
Enrollment	300 participants
Start Date	2026-02-17
Primary Completion	2028-08 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-11